These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 34178702)
1. Retraction: Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study. Frontiers Editorial Office Front Oncol; 2021; 11():709636. PubMed ID: 34178702 [TBL] [Abstract][Full Text] [Related]
2. Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study. Zhang YY; Yang QS; Qing X; Li BR; Qian J; Wang Y; Ning BT Front Oncol; 2020; 10():538779. PubMed ID: 33194600 [TBL] [Abstract][Full Text] [Related]
3. Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen. Christ TN; Stock W; Knoebel RW J Oncol Pharm Pract; 2018 Jun; 24(4):299-308. PubMed ID: 28355969 [TBL] [Abstract][Full Text] [Related]
4. Successful use of octreotide as a chemoprotectant for prevention of PEG-asparaginase-induced pancreatitis. Buie LW; Moore J; van Deventer H Pharmacotherapy; 2014 Aug; 34(8):e149-51. PubMed ID: 25112526 [TBL] [Abstract][Full Text] [Related]
6. Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study. Albertsen BK; Grell K; Abrahamsson J; Lund B; Vettenranta K; Jónsson ÓG; Frandsen TL; Wolthers BO; Heyman M; Schmiegelow K J Clin Oncol; 2019 Jul; 37(19):1638-1646. PubMed ID: 30978155 [TBL] [Abstract][Full Text] [Related]
7. Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocol. Raja RA; Schmiegelow K; Albertsen BK; Prunsild K; Zeller B; Vaitkeviciene G; Abrahamsson J; Heyman M; Taskinen M; Harila-Saari A; Kanerva J; Frandsen TL; Br J Haematol; 2014 Apr; 165(1):126-33. PubMed ID: 24428625 [TBL] [Abstract][Full Text] [Related]
8. Correlation of L-asp Activity, Anti-L-asp Antibody, Asn and Gln With Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL Patients. Wu J; Chen C; Huang S; Shen S; Chen J; Zhang S Technol Cancer Res Treat; 2020; 19():1533033820980113. PubMed ID: 33287663 [TBL] [Abstract][Full Text] [Related]
9. L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage. Top PC; Tissing WJ; Kuiper JW; Pieters R; van Eijck CH Pediatr Blood Cancer; 2005 Jan; 44(1):95-7. PubMed ID: 15368548 [TBL] [Abstract][Full Text] [Related]
10. Retraction: Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLCϵ/PKCϵ Signaling Pathway. Frontiers Editorial Office Front Oncol; 2021; 11():707608. PubMed ID: 34136414 [TBL] [Abstract][Full Text] [Related]
11. Toxicity Profile of PEG-Asparaginase in Adult Patients With Acute Lymphoblastic Leukemia in Brazil: A Multicenter Cross-Sectional Study. Silva WFD; Massaut IHB; Bendlin RM; Rosa LI; Velloso EDRP; Rego EM; Rocha V Clin Lymphoma Myeloma Leuk; 2020 Aug; 20(8):e523-e528. PubMed ID: 32389674 [TBL] [Abstract][Full Text] [Related]
12. Retraction: The value, diagnostic efficacy and clinical significance of functional magnetic resonance imaging in evaluating the efficacy of neoadjuvant chemotherapy in patients with triple negative breast cancer. Frontiers Editorial Office Front Oncol; 2024; 14():1383383. PubMed ID: 38450197 [TBL] [Abstract][Full Text] [Related]
13. An open-label, multicenter study of polyethylene glycol-L-asparaginase for the treatment of acute lymphoblastic leukemia. Ettinger LJ; Kurtzberg J; Voûte PA; Jürgens H; Halpern SL Cancer; 1995 Mar; 75(5):1176-81. PubMed ID: 7850718 [TBL] [Abstract][Full Text] [Related]
14. Retraction: Effects of Aidi injection on life quality and incidence of adverse reactions in patients with non-small cell lung cancer compared with traditional chemotherapy: a systematic review and meta-analysis. Frontiers Editorial Office Front Oncol; 2024; 14():1383346. PubMed ID: 38440226 [TBL] [Abstract][Full Text] [Related]
16. Retraction: The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: a retrospective analysis. Frontiers Editorial Office Front Oncol; 2024; 14():1383410. PubMed ID: 38444679 [TBL] [Abstract][Full Text] [Related]